Guilin Sanjin Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002275.SZ

Guilin Sanjin Pharmaceutical Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2023: 585,137,207

Guilin Sanjin Pharmaceutical Co., Ltd. Shares (Diluted, Weighted) is 585,137,207 for the year ending December 31, 2023, a -0.41% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

Guilin Sanjin Pharmaceutical Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2022 was 587,568,600, a 2.14% change year over year.
Guilin Sanjin Pharmaceutical Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2021 was 575,272,649, a 0.00% change year over year.
Guilin Sanjin Pharmaceutical Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2020 was 575,272,649, a -1.71% change year over year.
Guilin Sanjin Pharmaceutical Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2019 was 585,287,584, a -0.88% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

Shenzhen Stock Exchange: 002275.SZ

Guilin Sanjin Pharmaceutical Co., Ltd.

CEO	Mr. Xun Zou
IPO Date	July 10, 2009
Location	China
Headquarters	No.1, Gold Star(Jinxing) Road
Employees	2,615
Sector	Healthcare
Industries Pharmaceuticals Cosmetics Frozen Foods Non-Alcoholic Beverages Personal Care Pet Food Soft Drinks & Sodas Tobacco

Description

Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, and sale of traditional Chinese and natural medicines in China. The company primarily offers Guilin watermelon frost and lozenge, and Sanjin tablets under the Chinese TCM brand; and Naomaitai capsules, etc. It also produces TCM preparations. The company was founded in 1967 and is headquartered in Guilin, China. Guilin Sanjin Pharmaceutical Co., Ltd. operates as a subsidiary of Guilin SanJin Group Co.,Ltd.

Key trends

Past 5 years